Copyright Reports & Markets. All rights reserved.

Global Branded Generics Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Branded Generics Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Branded Generics Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Branded Generics Market Size Growth Rate by Type
    • 1.4.2 Oral
    • 1.4.3 Parenteral
    • 1.4.4 Topical
    • 1.4.5 Other
  • 1.5 Market by Application
    • 1.5.1 Global Branded Generics Market Size Growth Rate by Application
    • 1.5.2 Oncology
    • 1.5.3 Cardiovascular Diseases
    • 1.5.4 Diabetes
    • 1.5.5 Neurology
    • 1.5.6 Gastrointestinal Diseases
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Branded Generics Market Size, Estimates and Forecasts
    • 2.1.1 Global Branded Generics Revenue 2015-2026
    • 2.1.2 Global Branded Generics Sales 2015-2026
  • 2.2 Global Branded Generics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Branded Generics Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Branded Generics Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Branded Generics Competitor Landscape by Players

  • 3.1 Branded Generics Sales by Manufacturers
    • 3.1.1 Branded Generics Sales by Manufacturers (2015-2020)
    • 3.1.2 Branded Generics Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Branded Generics Revenue by Manufacturers
    • 3.2.1 Branded Generics Revenue by Manufacturers (2015-2020)
    • 3.2.2 Branded Generics Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Branded Generics Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Branded Generics Revenue in 2019
    • 3.2.5 Global Branded Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Branded Generics Price by Manufacturers
  • 3.4 Branded Generics Manufacturing Base Distribution, Product Types
    • 3.4.1 Branded Generics Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Branded Generics Product Type
    • 3.4.3 Date of International Manufacturers Enter into Branded Generics Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Branded Generics Market Size by Type (2015-2020)
    • 4.1.1 Global Branded Generics Sales by Type (2015-2020)
    • 4.1.2 Global Branded Generics Revenue by Type (2015-2020)
    • 4.1.3 Branded Generics Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Branded Generics Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Branded Generics Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Branded Generics Revenue Forecast by Type (2021-2026)
    • 4.2.3 Branded Generics Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Branded Generics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Branded Generics Market Size by Application (2015-2020)
    • 5.1.1 Global Branded Generics Sales by Application (2015-2020)
    • 5.1.2 Global Branded Generics Revenue by Application (2015-2020)
    • 5.1.3 Branded Generics Price by Application (2015-2020)
  • 5.2 Branded Generics Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Branded Generics Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Branded Generics Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Branded Generics Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Branded Generics by Country
    • 6.1.1 North America Branded Generics Sales by Country
    • 6.1.2 North America Branded Generics Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Branded Generics Market Facts & Figures by Type
  • 6.3 North America Branded Generics Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Branded Generics by Country
    • 7.1.1 Europe Branded Generics Sales by Country
    • 7.1.2 Europe Branded Generics Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Branded Generics Market Facts & Figures by Type
  • 7.3 Europe Branded Generics Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Branded Generics by Region
    • 8.1.1 Asia Pacific Branded Generics Sales by Region
    • 8.1.2 Asia Pacific Branded Generics Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Branded Generics Market Facts & Figures by Type
  • 8.3 Asia Pacific Branded Generics Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Branded Generics by Country
    • 9.1.1 Latin America Branded Generics Sales by Country
    • 9.1.2 Latin America Branded Generics Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Branded Generics Market Facts & Figures by Type
  • 9.3 Central & South America Branded Generics Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Branded Generics by Country
    • 10.1.1 Middle East and Africa Branded Generics Sales by Country
    • 10.1.2 Middle East and Africa Branded Generics Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Branded Generics Market Facts & Figures by Type
  • 10.3 Middle East and Africa Branded Generics Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Mylan NV
    • 11.1.1 Mylan NV Corporation Information
    • 11.1.2 Mylan NV Description and Business Overview
    • 11.1.3 Mylan NV Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Mylan NV Branded Generics Products Offered
    • 11.1.5 Mylan NV Related Developments
  • 11.2 Novartis AG
    • 11.2.1 Novartis AG Corporation Information
    • 11.2.2 Novartis AG Description and Business Overview
    • 11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis AG Branded Generics Products Offered
    • 11.2.5 Novartis AG Related Developments
  • 11.3 Eva Pharmaceutical Industries
    • 11.3.1 Eva Pharmaceutical Industries Corporation Information
    • 11.3.2 Eva Pharmaceutical Industries Description and Business Overview
    • 11.3.3 Eva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Eva Pharmaceutical Industries Branded Generics Products Offered
    • 11.3.5 Eva Pharmaceutical Industries Related Developments
  • 11.4 Pfizer
    • 11.4.1 Pfizer Corporation Information
    • 11.4.2 Pfizer Description and Business Overview
    • 11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Pfizer Branded Generics Products Offered
    • 11.4.5 Pfizer Related Developments
  • 11.5 Sun Pharmaceutical Industries
    • 11.5.1 Sun Pharmaceutical Industries Corporation Information
    • 11.5.2 Sun Pharmaceutical Industries Description and Business Overview
    • 11.5.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Sun Pharmaceutical Industries Branded Generics Products Offered
    • 11.5.5 Sun Pharmaceutical Industries Related Developments
  • 11.6 Aspen Pharmacare Holding
    • 11.6.1 Aspen Pharmacare Holding Corporation Information
    • 11.6.2 Aspen Pharmacare Holding Description and Business Overview
    • 11.6.3 Aspen Pharmacare Holding Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Aspen Pharmacare Holding Branded Generics Products Offered
    • 11.6.5 Aspen Pharmacare Holding Related Developments
  • 11.7 Abbott Laboratories
    • 11.7.1 Abbott Laboratories Corporation Information
    • 11.7.2 Abbott Laboratories Description and Business Overview
    • 11.7.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Abbott Laboratories Branded Generics Products Offered
    • 11.7.5 Abbott Laboratories Related Developments
  • 11.8 Bausch Health
    • 11.8.1 Bausch Health Corporation Information
    • 11.8.2 Bausch Health Description and Business Overview
    • 11.8.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Bausch Health Branded Generics Products Offered
    • 11.8.5 Bausch Health Related Developments
  • 11.1 Mylan NV
    • 11.1.1 Mylan NV Corporation Information
    • 11.1.2 Mylan NV Description and Business Overview
    • 11.1.3 Mylan NV Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Mylan NV Branded Generics Products Offered
    • 11.1.5 Mylan NV Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Branded Generics Market Estimates and Projections by Region
    • 12.1.1 Global Branded Generics Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Branded Generics Revenue Forecast by Regions 2021-2026
  • 12.2 North America Branded Generics Market Size Forecast (2021-2026)
    • 12.2.1 North America: Branded Generics Sales Forecast (2021-2026)
    • 12.2.2 North America: Branded Generics Revenue Forecast (2021-2026)
    • 12.2.3 North America: Branded Generics Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Branded Generics Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Branded Generics Sales Forecast (2021-2026)
    • 12.3.2 Europe: Branded Generics Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Branded Generics Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Branded Generics Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Branded Generics Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Branded Generics Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Branded Generics Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Branded Generics Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Branded Generics Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Branded Generics Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Branded Generics Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Branded Generics Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Branded Generics Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Branded Generics Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Branded Generics Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Branded Generics Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Branded Generics Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Branded Generics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Branded Generics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Branded Generics market is segmented into
    Oral
    Parenteral
    Topical
    Other

    Segment by Application, the Branded Generics market is segmented into
    Oncology
    Cardiovascular Diseases
    Diabetes
    Neurology
    Gastrointestinal Diseases

    Regional and Country-level Analysis
    The Branded Generics market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Branded Generics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Branded Generics Market Share Analysis
    Branded Generics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Branded Generics business, the date to enter into the Branded Generics market, Branded Generics product introduction, recent developments, etc.

    The major vendors covered:
    Mylan NV
    Novartis AG
    Eva Pharmaceutical Industries
    Pfizer
    Sun Pharmaceutical Industries
    Aspen Pharmacare Holding
    Abbott Laboratories
    Bausch Health

    Buy now